While dampening the immune system and thus stimulation of the PD-1/PD-L1 axis is a potential pathway to reduce progression of atherosclerosis, activation of the immune system by blockade of the PD-1/PD-L1 pathway has shown promising results in the treatment of several cancers (47). This evidence concerns the gene CD274 and cancer.